Skip to main content
Menu
Lei Clifton

Dr

Lei Clifton PhD

Lead Medical Statistician

Official Fellow in AI & Machine Learning, Reuben College

Biography

Lei is affiliated with the "AI for Healthcare'' CHI Lab led by Prof David Clifton, and currently leads a group of 3-4 researchers in the Nuffield Department of Population Health. She also leads analytical work in the Pandemic Science Institute on effective pandemic preparedness and response. Lei is a senior advisor of the NIHR Research Support Service team, which provides free advice on research design to researchers.

Lei was awarded a PhD in Statistical Machine Learning in 2007 from UMIST (now the University of Manchester), and subsequently worked as a post-doctoral researcher and then a medical statistician in the University of Oxford. She enjoys painting watercolours and playing violin, both amateurishly, in her spare time.

Profile Page

Other Information

Statistical and machine learning expertise in large-scale clinical records.

Most Recent Publications

Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.

Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.

Altmetric score is

Figure 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Figure 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Altmetric score is

Supplementary Table S2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Table S2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Altmetric score is

Supplementary Table S5 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Table S5 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Altmetric score is

Supplementary Figure S3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Figure S3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Altmetric score is
View all

Research Interests

Lei's research interests are in the field of medical statistics and AI, for large-scale observational studies and electronic health records.

Most Recent Publications

Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.

Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.

Altmetric score is

Figure 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Figure 3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Altmetric score is

Supplementary Table S2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Table S2 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Altmetric score is

Supplementary Table S5 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Table S5 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Altmetric score is

Supplementary Figure S3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Supplementary Figure S3 from Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank

Altmetric score is
View all